Botox® is a well-established neurologic treatment for people with chronic migraine, particularly when migraine remains frequent or disabling despite standard preventive medications.
For many patients, Botox® can meaningfully reduce headache frequency, severity, and reliance on acute medications.
It is not a cure, and it does not work for everyone, which is why expert patient selection, use of established treatment protocols, and ongoing reassessment are essential.
When used appropriately and for the right indications, it is a valuable option within a comprehensive migraine care plan.
We offer a dedicated Botox® Program for patients with chronic migraine and other headache disorders where Botox ® is supported by clinical evidence (e.g., trigeminal neuralgia).
Botox® is a well-established, neurologic treatment for chronic migraine, and in selected cases may also be used off-label for other headache conditions when evidence supports benefit and standard treatments are insufficient or not tolerated.
Our program emphasizes careful patient selection, evidence-based use, and individualized treatment planning.
Specialist assessment to determine whether Botox® is appropriate
Evidence-based use of Botox® for chronic migraine
Consideration of off-label Botox® use when supported by data
Standardized injection protocols
Longitudinal follow-up to assess response and adjust care
Assistance with insurance approval and documentation
Coordination with family physicians and other specialists
The Ottawa Headache Centre Botox® Program may help you if you:
Have chronic migraine (15 or more headache days per month and 8 or more migraine days per month)
Have tried other preventive medications without sufficient relief
Cannot tolerate oral preventive medications due to side effects
Prefer a non-daily preventive option
Have another headache disorder where Botox® may be beneficial based on evidence
Injecting Botox® for migraine is a specialized skill. At the Ottawa Headache Centre you can expect:
Neurological expertise: Our injectors are neurologists and specialist physicians who understand the complex anatomy of migraine pain pathways and how Botox® is part of the broader migraine plan. Learn more about who we are.
Precision injection: We follow the PREEMPT protocol, involving 31 precise injection sites across the head and neck to ensure maximum efficacy.
Judicious patient-centred care: We don't just "push injections". We stand firmly by ethical use of Botox®, carefully selecting those who may benefit, and offering alternative treatments.
A thorough assessment to confirm your diagnosis and ensure Botox® is the safest, most effective option for you.
Using the only proven injection protocol, with very fine needle, your specialist will perform a series of small precise injections into muscles around the forehead, temples, back of the head, and neck.
There is no downtime. You can drive yourself home and return to your daily routine immediately.
To maintain its effect, treatments are typically scheduled every 12 weeks.
Botox® (onabotulinumtoxinA) is a medication that works by reducing abnormal nerve signaling involved in headache disorders.
For headache treatment, Botox® is not cosmetic. It is injected into specific muscles of the head and neck using a standardized medical protocol.
Botox® is:
A preventive treatment, not an acute pain medication
Administered at regular intervals, not taken daily
Used according to a specific, evidence-based injection protocol for chronic migraine
Botox® is not a cure for migraine and does not eliminate all headaches, but it can significantly reduce migraine burden in appropriately selected patients.
Improvement with Botox® is often gradual, not immediate. For many patients, meaningful benefit includes:
A reduction in headache or migraine days
Reduced severity or shorter duration of attacks
Improved day-to-day function and quality of life
Reduced reliance on acute medications
Even partial improvement may be considered a success if it leads to meaningful improvement in daily functioning.
Botox® typically requires multiple treatment cycles to properly assess effectiveness.
Treatments are given every 12 weeks
Benefit is usually evaluated after 2–3 treatment cycles
Some patients notice early improvement, while others improve more gradually
For this reason, Botox® is best approached as a longitudinal treatment, with reassessment over time rather than as a single-trial intervention.
Botox® for headache is delivered using a standardized injection protocol. For chronic migraine, the only proven protocol is the PREEMPT protocol.
Small injections are placed across the:
Forehead
Temples
Back of the head
Upper neck
Shoulders
Typically 31 injection sites are targetted with very small needles. Most people describe the sensation as brief pinpricks.
Botox® is a powerful tool, but not a one-size-fits-all solution.
Our approach emphasizes:
Neurologist and specialist administered treatment
Administering Botox® using the only proven protocol for chronic migraine
Appropriate patient selection
Evidence-based and ethical use
Longitudinal care and reassessment
Botox® is one of several preventive options for chronic migraine, and its role depends on accurate diagnosis, prior treatments, and individual patient factors.
If you are considering Botox® or have been referred for assessment, our consultation allows us to:
Confirm whether Botox® is appropriate for your headache disorder
Review prior and current preventive treatments
Discuss realistic expectations and timelines
Determine whether Botox® fits within your broader, individualized migraine care plan
If Botox® is not the right option, we will explore alternative evidence-based preventive strategies.
Referrals are accepted from family physicians, nurse practitioners, and other doctors. Coordination of care and assistance with required documentation are part of our program.
Botox® has an established role in treating chronic migraine.
There is growing evidence supporting the use of Botox® for other specific headache disorders (e.g., refractory trigeminal neuralgia).
Botox® has not been shown to be effective for episodic migraine, or tension-type headache.
Botox® works by:
Reducing release of pain-related neurochemicals (including CGRP)
Decreasing sensitivity of pain pathways in the head and neck
Lowering the likelihood that migraine circuits are activated
Although injected into muscles, Botox’s ® primary effect in headache is neurologic, not muscular.
Botox ®:
Does not suppress the immune system
Does not cause sedation or brain fog
Does not circulate systemically in meaningful amounts
Botox® is an evidence-based, guideline-supported treatment for chronic migraine.
Clinical studies show Botox® can:
Reduce the number of headache days per month
Decrease migraine severity
Improve quality of life
Reduce reliance on acute medications
Benefit often increases over repeated treatment cycles.
Botox® may be considered off-label for other headache disorders when supported by evidence, such as:
Refractory trigeminal neuralgia
Certain refractory headache syndromes
Headache with prominent muscle-related pain components
Off-label use is:
Carefully discussed
Individualized
Based on symptom pattern, prior treatments, and available data
Not all headache types are appropriate for Botox®.
Botox® does not work immediately
Improvement often begins within 1–2 weeks
Full benefit is usually assessed after 2 treatment cycles (about 6 months)
Mild neck or shoulder soreness
Injection-site discomfort
Head tightness or pressure
Fatigue for a day or two
Temporary eyelid or eyebrow droop
Neck weakness
These effects are usually mild and reversible.
Botox® is typically given every 12 weeks (3 months).
Botox® can be used:
Alone
Alongside oral preventive medications
Alongside CGRP-targeted therapies (from a medical perspective although limited by insurer's policies)
Insurance plans may limit coverage of simultaneous advanced therapies, which we help navigate.
Yes.
Botox® use during pregnancy or breastfeeding is an area of growing evidence.
Our clinic:
Does offer Botox® during pregnancy in selected cases
Uses an individualized, evidence-informed approach
Reviews available safety data and uncertainties
Coordinates with obstetric care when appropriate
Botox® does not affect the immune system and does not cross the blood–brain barrier.
In Ontario, insurance coverage for Botox® often requires:
A diagnosis of chronic migraine
Prior trials of at least two oral preventive medications (or three oral preventive medications if applying through the Exceptional Access Program).
Documentation of headache frequency and disability
We assist with:
Insurance forms
Prior authorizations
Treatment sequencing
This material is provided for educational purposes and does not replace independent clinical judgment or institutional protocols. Management decisions remain the responsibility of the treating clinician.